If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced an upcoming presentation of preclinical data on the ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an ...

A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...

Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other ...

Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...

HC Wainwright reiterated their neutral rating on shares of Leap Therapeutics (NASDAQ:LPTX – Free Report) in a report ...